Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial
比较祖贝利单抗联合CHOP方案与利妥昔单抗联合CHOP方案治疗初治CD20阳性弥漫性大B细胞淋巴瘤患者的疗效：一项3期临床试验
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-008895
Li, Zhiming; Jiang, Wenqi; Zhou, Hui; Cen, Hong; Zhang, Mingzhi; Lv, Fangfang; Zhang, Qingyuan; Sun, Xiuhua; Liu, Lihong; Huang, Yunhong; Yang, Haiyan; Gao, Sujun; He, Chuan; Yang, Wei; Li, Wenyu; Yu, Ding; Yang, Yu; Cheng, Ying; Qian, Zhengzi; Xiang, Ying; Guo, Qunyi; Xu, Bing; Song, Yuqin; Zhang, Liling; Lin, Lie; Shen, Jianzhen; Yan, Feng; Liu, Huilan; Zhang, Donghua; Wang, Jishi; Zhou, Min; Zhu, Xiongpeng; Zhang, Weihua; Zhao, Weili; Feng, Ru; Zhang, Xiaohong; Jin, Jie; Zhong, Meizuo; Zhang, Mei; Wang, Jingbo; Jing, Hongmei; Wang, Zhao; Zhao, Hongguo; Zhu, Jun
B细胞
HOP
淋巴瘤
CHOP
CD20
细胞生物学
CD2
免疫/内分泌
